Skip to content

HIV infection increases risk of bone fractures for men, but not for younger women

Antiretroviral drugs have variable effects on bones and fat, lipoatrophy uncommon with modern regimens

Vitamin D deficiency extremely common among HIV-positive patients in diverse regions

Low bone mineral density common in HIV-positive men

Reassurance for HIV-positive women about short-term risk of bone loss

More evidence of bone loss with HIV therapy, more confusion over the role of specific drugs

Bone loss during HIV treatment most associated with protease inhibitors

Single dose of intravenous zoledronate shown to treat bone loss effectively for one year

High prevalence of vitamin D deficiency in patients with HIV